Pegylated interferon and ribavirin gone but not forgotten in the era of direct-acting antivirals.

Detection of favourable HCV and IL28B genotype prior to commencement of PEG-IFN+RBV, and continuing it in patients with EVR is of major importance for those in whom DAA are still unavailable.